priate protections for classified, sensitive, and per-
sonal information; 
(5) to coordinate through the White House Of-
fice of Science and Technology Policy, and across 
the science and technology enterprise of the Govern-
ment, the technological and research efforts of the 
Government to address suspected attacks presenting 
as anomalous health incidents; and 
(6) to develop policy options to prevent, miti-
gate, and deter suspected attacks presenting as 
anomalous health incidents. 
(c) 
DESIGNATION
OF
AGENCY
COORDINATION 
LEADS.— 
(1) IN GENERAL.—The head of each relevant 
agency shall designate a Senate-confirmed or other 
appropriate senior official, who shall— 
(A) serve as the Anomalous Health Inci-
dent Agency Coordination Lead for the relevant 
agency; 
(B) report directly to the head of the rel-
evant agency regarding activities carried out 
under this Act; 
(C) perform functions specific to the rel-
evant agency, consistent with the directives of 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
the Interagency Coordinator and the established 
interagency process; 
(D) participate in interagency briefings to 
Congress regarding the response of the United 
States Government to anomalous health inci-
dents; and 
(E) represent the relevant agency in meet-
ings convened by the Interagency Coordinator. 
(2) DELEGATION PROHIBITED.—An Agency Co-
ordination Lead may not delegate the responsibilities 
described in subparagraphs (A) through (C) of para-
graph (1). 
(d) SECURE REPORTING MECHANISMS.—Not later 
than 90 days after the date of the enactment of this Act, 
the Interagency Coordinator shall— 
(1) ensure that each relevant agency develops a 
process to provide a secure mechanism for personnel, 
their dependents, and other appropriate individuals 
to self-report any suspected exposure that could be 
an anomalous health incident; 
(2) ensure that each relevant agency shares all 
relevant data in a timely manner with the Office of 
the Director of National Intelligence, and other rel-
evant agencies, through existing processes coordi-
nated by the Interagency Coordinator; and 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
(3) in establishing the mechanism described in 
paragraph (1), prioritize secure information collec-
tion and handling processes to protect classified, 
sensitive, and personal information. 
(e) BRIEFINGS.— 
(1) IN GENERAL.—Not later than 60 days after 
the date of the enactment of this Act, and quarterly 
thereafter for the following 2 years, the Interagency 
Coordinator, the Deputy Coordinator, and the Agen-
cy Coordination Leads shall jointly provide a brief-
ing to the appropriate national security committees 
regarding progress in carrying out the duties under 
subsection (b), including the requirements under 
paragraph (2). 
(2) ELEMENTS.—The briefings required under 
paragraph (1) shall include— 
(A) an update on the investigation into 
anomalous health incidents impacting United 
States Government personnel and their family 
members, including technical causation and sus-
pected perpetrators; 
(B) an update on new or persistent inci-
dents; 
(C) threat prevention and mitigation ef-
forts to include personnel training; 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
(D) changes to operating posture due to 
anomalous health threats; 
(E) an update on diagnosis and treatment 
efforts for affected individuals, including pa-
tient numbers and wait times to access care; 
(F) efforts to improve and encourage re-
porting of incidents; 
(G) detailed roles and responsibilities of 
Agency Coordination Leads; 
(H) information regarding additional au-
thorities or resources needed to support the 
interagency response; and 
(I) other matters that the Interagency Co-
ordinator or the Agency Coordination Leads 
consider appropriate. 
(3) UNCLASSIFIED BRIEFING SUMMARY.—The 
Agency Coordination Leads shall provide a coordi-
nated, unclassified summary of the briefings to Con-
gress, which shall include as much information as 
practicable without revealing classified information 
or information that is likely to identify an individual. 
(f) RETENTION OF AUTHORITY.—The appointment 
of the Interagency Coordinator shall not deprive any Fed-
eral agency of any authority to independently perform its 
authorized functions. 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
(g) RULE OF CONSTRUCTION.—Nothing in this sec-
tion may be construed to limit— 
(1) the President’s authority under article II of 
the United States Constitution; or 
(2) the provision of health care and benefits to 
afflicted individuals, consistent with existing laws. 
SEC. 5. AUTHORIZATION OF APPROPRIATIONS. 
There is authorized to be appropriated— 
(1) to the Secretary of Defense $45,000,000 for 
fiscal year 2022, of which— 
(A) $30,000,000 shall be used— 
(i) to develop the necessary medical 
capacity to provide health assessments and 
appropriate care to United States Govern-
ment personnel, dependents, and other ap-
propriate individuals who have symptoms 
associated with anomalous health inci-
dents; 
(ii) to develop additional capability 
and capacity in the military healthcare sys-
tem to provide assessment and timely care 
to affected United States Government per-
sonnel, dependents, and other appropriate 
individuals; and 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
(iii) to fund the assessment and care 
of civilian employees of the Department of 
Defense and other Department of Defense- 
affiliated non-beneficiaries, if such funding 
is not otherwise available; and 
(B) the remaining $15,000,000 shall be 
used to support— 
(i) the efforts of the Department of 
Defense to investigate and characterize the 
cause of anomalous health incidents, in-
cluding investigations of technical causa-
tion, medical research, and other activities 
in support of attribution; 
(ii) intelligence and data analysis by 
the Department of Defense of information 
related to anomalous health incidents; and 
(iii) development and implementation 
by the Department of Defense of force pro-
tection and mitigation efforts; and 
(2) to the Secretary of State $5,000,000 for fis-
cal year 2022 to be used— 
(A) to increase capacity and staffing for 
the Health Incident Response Task Force of 
the Department of State; 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
(B) to support the development and imple-
mentation of efforts by the Department of 
State to prevent and mitigate anomalous health 
incidents affecting its workforce; 
(C) to investigate and characterize the 
cause of anomalous health incidents, including 
investigations of causation and attribution; 
(D) to collect and analyze data related to 
anomalous health incidents; 
(E) to coordinate with other relevant agen-
cies and the National Security Council regard-
ing anomalous health incidents; and 
(F) to support other activities to under-
stand, prevent, deter, and respond to suspected 
attacks presenting as anomalous health inci-
dents, at the discretion of the Secretary of 
State. 
SEC. 6. DEVELOPMENT AND DISSEMINATION OF WORK-
FORCE GUIDANCE. 
The President shall direct relevant agencies to de-
velop and disseminate to employees who are at risk of ex-
posure to anomalous health incidents, not later than 90 
days after the date of the enactment of this Act, updated 
workforce guidance to report, mitigate, and address sus-
pected attacks presenting as anomalous health incidents. 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
SEC. 7. DEFINITIONS. 
In this Act: 
(1) AGENCY COORDINATION LEAD.—The term 
‘‘Agency Coordination Lead’’ means a senior official 
designated by the head of a relevant agency to serve 
as the Anomalous Health Incident Agency Coordina-
tion Lead for such agency. 
(2) APPROPRIATE
NATIONAL
SECURITY
COM-
MITTEES.—The term ‘‘appropriate national security 
committees’’ means— 
(A) the Committee on Armed Services of 
the Senate; 
(B) the Committee on Foreign Relations of 
the Senate; 
(C) the Select Committee on Intelligence of 
the Senate; 
(D) the Committee on Homeland Security 
and Governmental Affairs of the Senate; 
(E) the Committee on the Judiciary of the 
Senate; 
(F) the Committee on Armed Services of 
the House of Representatives; 
(G) the Committee on Foreign Affairs of 
the House of Representatives; 
(H) the Permanent Select Committee on 
Intelligence of the House of Representatives; 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
(I) the Committee on Homeland Security 
of the House of Representatives; and 
(J) the Committee on the Judiciary of the 
House of Representatives. 
(3) DEPUTY COORDINATOR.—The term ‘‘Dep-
uty Coordinator’’ means the Deputy Anomalous 
Health Incidents Interagency Coordinator in the 
White House Office of Science and Technology Pol-
icy designated pursuant to section 4(a). 
(4) INTERAGENCY
COORDINATOR.—The term 
‘‘Interagency Coordinator’’ means the Anomalous 
Health Incidents Interagency Coordinator des-
ignated pursuant to section 4(a). 
(5) RELEVANT AGENCIES.—The term ‘‘relevant 
agencies’’ means— 
(A) the Department of Defense; 
(B) the Department of State; 
(C) the Office of the Director of National 
Intelligence; 
(D) the Central Intelligence Agency; 
(E) the Department of Justice; 
(F) the Department of Homeland Security; 
and 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS
(G) other agencies and bodies designated 
by the Interagency Coordinator. 
Æ 
VerDate Sep 11 2014 
20:10 Sep 16, 2021
Jkt 019200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6301
E:\BILLS\H5263.IH
H5263
pbinns on DSKJLVW7X2PROD with BILLS